Members Login
 

The WHO Early Release Guideline on ARV and PrEP

were published on September

30th, 2015 and can be

found here:

 Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV

JIAS Special Issue: PrEP Implementation Science: State-of-the-Art and Research Agenda, organized by NEMUS (published July 2015).

 Please visit Nemus´Youtube channell

 

Follow us in Facebook

 

and Twiter

The Network for Multidisciplinary Studies
on ARV-based HIV Prevention

welcome to

NEMUS

  • Science
  • Policy
  • HIV Prevention

Agenda

Please find here a list of activities planned for 2014 that are relevant to NEMUS' activities. This list is updated on a regular basis.

  • 23rd Conference on Retroviruses and Opportunistic Infections (CROI 2016)

    The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI is a global model of collaborative science and the premier international venue for bridging basic and clinical investigation to clinical practice in the field of HIV and related viruses. CROI 2016 will be held from February 22 to February 25, 2016, in Boston, Massachusetts, at the Hynes Convention Center. Webcasts, abstracts, electronic posters, and other electronic resources from CROI 2016 will be available online via webcast.

     

     

    Read more

    close
    23rd Conference on Retroviruses and Opportunistic Infections (CROI 2016)

    The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI is a global model of collaborative science and the premier international venue for bridging basic and clinical investigation to clinical practice in the field of HIV and related viruses. CROI 2016 will be held from February 22 to February 25, 2016, in Boston, Massachusetts, at the Hynes Convention Center. Webcasts, abstracts, electronic posters, and other electronic resources from CROI 2016 will be available online via webcast.

     

    Read more

  • HIV & Hepatitis Clinical Pharmacology Workshop 2016

    The 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy will provide a platform for state-of-the-art discussions of current topics fundamental to the optimal use of antiretroviral therapy including drug-drug interactions, pharmacokinetics of investigational agents and existing drugs, pharmacodynamics, drug dosing in special populations, post-marketing surveillance project, and regulatory considerations.

     

    The 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy will be held 8 - 10 June 2016 in Washington DC, USA.

     

     

    Read more

    close
    HIV & Hepatitis Clinical Pharmacology Workshop 2016

    The 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy will provide a platform for state-of-the-art discussions of current topics fundamental to the optimal use of antiretroviral therapy including drug-drug interactions, pharmacokinetics of investigational agents and existing drugs, pharmacodynamics, drug dosing in special populations, post-marketing surveillance project, and regulatory considerations.

     

    The 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy will be held 8 - 10 June 2016 in Washington DC, USA.

     

    Read more

  • 21st International AIDS Conference (AIDS 2016)

    The International AIDS Conference is the premier gathering for those working in the field of HIV, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic. It is a chance to assess where we are, evaluate recent scientific developments and lessons learnt, and collectively chart a course forward.

    The AIDS 2016 conference will be held at the Durban International Convention Centre (ICC) from 18 to 22 July 2016.

     

     

    Read more

    close
    21st International AIDS Conference (AIDS 2016)

    The International AIDS Conference is the premier gathering for those working in the field of HIV, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic. It is a chance to assess where we are, evaluate recent scientific developments and lessons learnt, and collectively chart a course forward.

    The AIDS 2016 conference will be held at the Durban International Convention Centre (ICC) from 18 to 22 July 2016.

     

    Read more

  • HIV Research for Prevention 2016: AIDS Vaccine, Microbicide, and ARV-based…

     

    HIVR4P is the world's only scientific meeting dedicated exclusively to the latest research on all forms of biomedical HIV prevention. Through both abstract and non-abstract-driven sessions, HIVR4P supports cross-fertilization among research on HIV vaccines, microbicides, PrEP, treatment as prevention, and other biomedical prevention approaches, while also providing a venue to discuss the research findings, questions, and priorities that are specific to each modality. We expect this cutting-edge, global conference to attract between 1,200 and 1,500 leaders in HIV prevention research, programs, and policy to Chicago.

    Join an expected 1,500 leaders in HIV prevention research, programs, and policy at HIVR4P 2016, 17-20 October in Chicago.

     

    Read more

    close
    HIV Research for Prevention 2016: AIDS Vaccine, Microbicide, and ARV-based Prevention Science (HIVR4P 2016)

     

    HIVR4P is the world's only scientific meeting dedicated exclusively to the latest research on all forms of biomedical HIV prevention. Through both abstract and non-abstract-driven sessions, HIVR4P supports cross-fertilization among research on HIV vaccines, microbicides, PrEP, treatment as prevention, and other biomedical prevention approaches, while also providing a venue to discuss the research findings, questions, and priorities that are specific to each modality. We expect this cutting-edge, global conference to attract between 1,200 and 1,500 leaders in HIV prevention research, programs, and policy to Chicago.

    Join an expected 1,500 leaders in HIV prevention research, programs, and policy at HIVR4P 2016, 17-20 October in Chicago.

    Read more

  • 19th Annual United States Conference on AIDS 2015

     

    The 19th annual United States Conference on AIDS(USCA), will take place September 10-13, 2015, at the new Washington Marriott Marquis hotel located at 901 Massachusetts Avenue, NW in Washington, DC. For nearly two decades, USCA has sought to increase the strength and diversity of the community-based response to the HIV/AIDS epidemic through education, training, new partnerships, collaboration and networking.

     

     

    Read more

    close
    19th Annual United States Conference on AIDS 2015

     

    The 19th annual United States Conference on AIDS(USCA), will take place September 10-13, 2015, at the new Washington Marriott Marquis hotel located at 901 Massachusetts Avenue, NW in Washington, DC. For nearly two decades, USCA has sought to increase the strength and diversity of the community-based response to the HIV/AIDS epidemic through education, training, new partnerships, collaboration and networking.

     

    Read more

  • International Society for Sexually Transmitted Diseases Research 2015

     

    The International Society for Sexually Transmitted Diseases Research exists to promote research on sexually transmitted diseases and facilitate the timely exchange of information among research investigators. To these ends, ISSTDR sponsors a biennial, interdisciplinary scientific meeting, at venues that historically have alternated between Europe and North America. During the three decades since the Society was founded, the ISSTDR meetings have been the premier scientific conferences that address the entire breadth of research on STD, including HIV infections and the acquired immunodeficiency syndrome, and encompassing microbiology, virology, immunobiology, pathogenesis, and other basic sciences; clinical sciences, social and behavioral sciences, epidemiology, and prevention; and research in health services, public health, and prevention policy.

     

    ISSTDR was founded in 1977 and is governed by an international Board of Directors who currently represent 7 countries. The ISSTDR Conference Support Foundation provides support in respect of the conferences of the ISSTDR.

     

    The 21st Meeting of the ISSTDR will take place as a joint meeting with IUSTI World at the Brisbane Convention and Exhibition Centre, Australia from September 13 to 16, 2015.

     

     

    Read more

    close
    International Society for Sexually Transmitted Diseases Research 2015

     

    The International Society for Sexually Transmitted Diseases Research exists to promote research on sexually transmitted diseases and facilitate the timely exchange of information among research investigators. To these ends, ISSTDR sponsors a biennial, interdisciplinary scientific meeting, at venues that historically have alternated between Europe and North America. During the three decades since the Society was founded, the ISSTDR meetings have been the premier scientific conferences that address the entire breadth of research on STD, including HIV infections and the acquired immunodeficiency syndrome, and encompassing microbiology, virology, immunobiology, pathogenesis, and other basic sciences; clinical sciences, social and behavioral sciences, epidemiology, and prevention; and research in health services, public health, and prevention policy.

     

    ISSTDR was founded in 1977 and is governed by an international Board of Directors who currently represent 7 countries. The ISSTDR Conference Support Foundation provides support in respect of the conferences of the ISSTDR.

     

    The 21st Meeting of the ISSTDR will take place as a joint meeting with IUSTI World at the Brisbane Convention and Exhibition Centre, Australia from September 13 to 16, 2015.

     

    Read more

NEMUS' Activities

  • Special NEMUS Global Webinar Program for World AIDS Day #26…

    Dear colleague:

     

    On occasion of World AIDS Day 2016, NEMUS is pleased to offer a Special Program of 3 presentation of its Global Webinar Series: the second on Monday 28 November, Raphael Landovitz, MD, who was one of the Lead Rapporteurs at the recent R4P Conference, will present on 

     

    ARV-based prevention and PrEP research - News from the 2016 Research for Prevention Conference
    (28 November)

    Rafael Landovitz

    Raphael J Landovitz´s clinical research career focuses on optimizing the use of HIV antiretroviral therapy for both HIV treatment and HIV prevention.
    Dr. Landovitz was trained at Princeton University and Harvard Medical School. He completed post-graduate training in internal medicine at Brigham and Women’s Hospital (1996-1999) and Infectious Diseases and HIV Medicine at Brigham and Women’s Hospital and Massachusetts General Hospital (1999-2001). The served as Chief Medical Resident at the Brigham and Women’s Hospital from 2001-2002. He served on the faculty of the Division of Infectious Diseases at the Brigham and Women’s Hospital from 2001-2005, and then as Medical Co-Director of the Vietnam CDC-Harvard Medical School AIDS Partnership. He is Currently Associate Professor of Medicine in the Division of Infectious Diseases at UCLA, Associate Director of the UCLA Center for Clinical AIDS Research & Education, and Co-Director of the UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS). He is leading the NIH/DAIDS funded Phase 2a and Phase 3 studies of long-acting injectable PrEP using cabotegravir (GSK 1265744). He was awarded the John Carey Young Investigator Award by the AIDS Clinical Trials Group in 2010..

     

     

     

    Read more

    close
    wxxxxxxxxxx
    Special NEMUS Global Webinar Program for World AIDS Day #26 "ARV-based prevention and PrEP research - News from the 2016 Research for Prevention Conference"

    Dear colleague:

     

    On occasion of World AIDS Day 2016, NEMUS is pleased to offer a Special Program of 3 presentation of its Global Webinar Series: the second on Monday 28 November, Raphael Landovitz, MD, who was one of the Lead Rapporteurs at the recent R4P Conference, will present on 

     

    ARV-based prevention and PrEP research - News from the 2016 Research for Prevention Conference
    (28 November)

    Rafael Landovitz

    Raphael J Landovitz´s clinical research career focuses on optimizing the use of HIV antiretroviral therapy for both HIV treatment and HIV prevention.
    Dr. Landovitz was trained at Princeton University and Harvard Medical School. He completed post-graduate training in internal medicine at Brigham and Women’s Hospital (1996-1999) and Infectious Diseases and HIV Medicine at Brigham and Women’s Hospital and Massachusetts General Hospital (1999-2001). The served as Chief Medical Resident at the Brigham and Women’s Hospital from 2001-2002. He served on the faculty of the Division of Infectious Diseases at the Brigham and Women’s Hospital from 2001-2005, and then as Medical Co-Director of the Vietnam CDC-Harvard Medical School AIDS Partnership. He is Currently Associate Professor of Medicine in the Division of Infectious Diseases at UCLA, Associate Director of the UCLA Center for Clinical AIDS Research & Education, and Co-Director of the UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS). He is leading the NIH/DAIDS funded Phase 2a and Phase 3 studies of long-acting injectable PrEP using cabotegravir (GSK 1265744). He was awarded the John Carey Young Investigator Award by the AIDS Clinical Trials Group in 2010..

     

     

    Read more

  • Special NEMUS Global Webinar Program for World AIDS Day #25…

    Dear colleague:

     

    On occasion of World AIDS Day 2016, NEMUS is pleased to offer a Special Program of 3 presentation of its Global Webinar Series, the first one On Tuesday 22 November, Sybil Hosek, PhD and Alejandra Trossero, MA, will present on an increasingly important topic globally:

     

    PrEP and Adolescents at Risk: Existing Evidence and Plans for a Demonstration Study
    (22 November)

    sibil hosek

    Sybil Hosek is a Clinical Psychologist/HIV Researcher at Stroger Hospital of Cook County with over 15 years experience in the development and implementation of HIV-related research studies and behavioral interventions. Her current research focuses on biomedical primary prevention interventions, for adolescents and young adults, including PrEP and microbicides, and the development of behavioral interventions to improve uptake and adherence to these new biomedical strategies. Dr. Hosek is currently vice-chair of the IMPAACT Prevention Scientific Committee, a member of the HPTN Adolescents At Risk Scientific Committee, and co-chair of the HANC Youth Prevention Research Working Group.

     

    Alejandra Trossero

    Alejandra Trossero recently joined UNICEF Latin American and the Caribbean Regional office as the Regional Adolescent and HIV/AIDS Specialist. Alejandra has over 18 years of experience working on HIV and sexual and reproductive health (SRH). Prior to joining UNICEF, she hold positions at UNDP and the International Planned Parenthood Federation (IPPF), focusing on HIV and SRH integration, establishing a 5-year research program in three Sub-Saharan Africa countries to assess the efficacy and cost-benefit of integrating HIV and SRH services – with Population Council and London School of Hygiene and Tropical Medicine. She is currently serving as the Chair of the Program Advisory Panel at the Robert Carr Civil Society Network Fund. Alejandra, who hails from Argentina, has a degree in Psychology and a Masters in Science in Reproductive and Sexual Health Research from the London School of Hygiene and Tropical Medicine.

     

     

     

    Read more

    close
    wxxxxxxxxxx
    Special NEMUS Global Webinar Program for World AIDS Day #25 "PrEP and Adolescents at Risk: Existing Evidence and Plans for a Demonstration Study"

    Dear colleague:

     

    On occasion of World AIDS Day 2016, NEMUS is pleased to offer a Special Program of 3 presentation of its Global Webinar Series, the first one On Tuesday 22 November, Sybil Hosek, PhD and Alejandra Trossero, MA, will present on an increasingly important topic globally:

     

    PrEP and Adolescents at Risk: Existing Evidence and Plans for a Demonstration Study
    (22 November)

    sibil hosek

    Sybil Hosek is a Clinical Psychologist/HIV Researcher at Stroger Hospital of Cook County with over 15 years experience in the development and implementation of HIV-related research studies and behavioral interventions. Her current research focuses on biomedical primary prevention interventions, for adolescents and young adults, including PrEP and microbicides, and the development of behavioral interventions to improve uptake and adherence to these new biomedical strategies. Dr. Hosek is currently vice-chair of the IMPAACT Prevention Scientific Committee, a member of the HPTN Adolescents At Risk Scientific Committee, and co-chair of the HANC Youth Prevention Research Working Group.

     

    Alejandra Trossero

    Alejandra Trossero recently joined UNICEF Latin American and the Caribbean Regional office as the Regional Adolescent and HIV/AIDS Specialist. Alejandra has over 18 years of experience working on HIV and sexual and reproductive health (SRH). Prior to joining UNICEF, she hold positions at UNDP and the International Planned Parenthood Federation (IPPF), focusing on HIV and SRH integration, establishing a 5-year research program in three Sub-Saharan Africa countries to assess the efficacy and cost-benefit of integrating HIV and SRH services – with Population Council and London School of Hygiene and Tropical Medicine. She is currently serving as the Chair of the Program Advisory Panel at the Robert Carr Civil Society Network Fund. Alejandra, who hails from Argentina, has a degree in Psychology and a Masters in Science in Reproductive and Sexual Health Research from the London School of Hygiene and Tropical Medicine.

     

     

    Read more

  • Special NEMUS Global Webinar Program for World AIDS Day (Webinars…

    Dear colleague:

     

    On occasion of World AIDS Day 2016, NEMUS is pleased to offer a Special Program of 3 presentation of its Global Webinar Series:

    -  On Tuesday 22 November, Sybil Hosek, PhD and Alejandra Trossero, MA, will present on an increasingly important topic globally: PrEP and Adolescents at Risk: Existing Evidence and Plans for a Demonstration Study.

    -  On Monday 28 November, Raphael Landovitz, MD, who was one of the Lead Rapporteurs at the recent R4P Conference, will present on ARV-based prevention and PrEP research - News from the 2016 Research for Prevention Conference.

    -  On Monday, 5 December, Jerome Galea, PhD, who is in charge of the PrEP in the Wild Study of individual/community led access to PrEP, will present on PrEP in the Wild - An interim Analysis.


    All webinars will take place at 7am (PST), 9am (Mexico City) 10am (EST, Lima, Panama), 12m (Buenos Aires), 1pm (Brasilia, Rio), 3pm (London), 4pm (CST), 5pm (Johannesburg), 10pm (Bangkok), 2am+1 (Sydney). For other locations, please check:

     

    http://www.worldtimeserver.com/meeting-planner.aspx

     

    PrEP and Adolescents at Risk: Existing Evidence and Plans for a Demonstration Study
    (22 November)

    sibil hosek

    Sybil Hosek is a Clinical Psychologist/HIV Researcher at Stroger Hospital of Cook County with over 15 years experience in the development and implementation of HIV-related research studies and behavioral interventions. Her current research focuses on biomedical primary prevention interventions, for adolescents and young adults, including PrEP and microbicides, and the development of behavioral interventions to improve uptake and adherence to these new biomedical strategies. Dr. Hosek is currently vice-chair of the IMPAACT Prevention Scientific Committee, a member of the HPTN Adolescents At Risk Scientific Committee, and co-chair of the HANC Youth Prevention Research Working Group.

     

    Alejandra Trossero

    Alejandra Trossero recently joined UNICEF Latin American and the Caribbean Regional office as the Regional Adolescent and HIV/AIDS Specialist. Alejandra has over 18 years of experience working on HIV and sexual and reproductive health (SRH). Prior to joining UNICEF, she hold positions at UNDP and the International Planned Parenthood Federation (IPPF), focusing on HIV and SRH integration, establishing a 5-year research program in three Sub-Saharan Africa countries to assess the efficacy and cost-benefit of integrating HIV and SRH services – with Population Council and London School of Hygiene and Tropical Medicine. She is currently serving as the Chair of the Program Advisory Panel at the Robert Carr Civil Society Network Fund. Alejandra, who hails from Argentina, has a degree in Psychology and a Masters in Science in Reproductive and Sexual Health Research from the London School of Hygiene and Tropical Medicine.

    To register for the webinar please click on the following link:

     

    https://goo.gl/forms/gHS3HsaflKdvBpU02

     

    ARV-based prevention and PrEP research - News from the 2016 Research for Prevention Conference
    (28 November)

    Rafael Landovitz

    Raphael J Landovitz´s clinical research career focuses on optimizing the use of HIV antiretroviral therapy for both HIV treatment and HIV prevention.
    Dr. Landovitz was trained at Princeton University and Harvard Medical School. He completed post-graduate training in internal medicine at Brigham and Women’s Hospital (1996-1999) and Infectious Diseases and HIV Medicine at Brigham and Women’s Hospital and Massachusetts General Hospital (1999-2001). The served as Chief Medical Resident at the Brigham and Women’s Hospital from 2001-2002. He served on the faculty of the Division of Infectious Diseases at the Brigham and Women’s Hospital from 2001-2005, and then as Medical Co-Director of the Vietnam CDC-Harvard Medical School AIDS Partnership. He is Currently Associate Professor of Medicine in the Division of Infectious Diseases at UCLA, Associate Director of the UCLA Center for Clinical AIDS Research & Education, and Co-Director of the UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS). He is leading the NIH/DAIDS funded Phase 2a and Phase 3 studies of long-acting injectable PrEP using cabotegravir (GSK 1265744). He was awarded the John Carey Young Investigator Award by the AIDS Clinical Trials Group in 2010..

    To register for the webinar please click on the following link:

     

    https://goo.gl/forms/2BxXvMKKGb0AYsKI2

     

    PrEP in the Wild - An interim Analysis
    (05 December)

    Jerome Galea

    Jerome Galea is the Deputy Director of Partners in Health and the co-founder of the LGTB Epicenter community center, both organizations in Lima, Peru, and a postdoctoral Fellow at the Harvard Medical School. He has studied and published on the acceptability of PrEP in Peru and is currently investigating the informal use of PrEP in the Wild PrEP study.

    To register for the webinar please click on the following link:

     

    https://goo.gl/forms/0xsEvSQuFL8BHflE2

     

    After you register you will receive a confirmation e-mail with instructions to access the webinar and background readings.Looking forward to your participation. 

     

     

    Read more

    close
    wxxxxxxxxxx
    Special NEMUS Global Webinar Program for World AIDS Day (Webinars 25, 26 and 27)

    Dear colleague:

     

    On occasion of World AIDS Day 2016, NEMUS is pleased to offer a Special Program of 3 presentation of its Global Webinar Series:

    -  On Tuesday 22 November, Sybil Hosek, PhD and Alejandra Trossero, MA, will present on an increasingly important topic globally: PrEP and Adolescents at Risk: Existing Evidence and Plans for a Demonstration Study.

    -  On Monday 28 November, Raphael Landovitz, MD, who was one of the Lead Rapporteurs at the recent R4P Conference, will present on ARV-based prevention and PrEP research - News from the 2016 Research for Prevention Conference.

    -  On Monday, 5 December, Jerome Galea, PhD, who is in charge of the PrEP in the Wild Study of individual/community led access to PrEP, will present on PrEP in the Wild - An interim Analysis.


    All webinars will take place at 7am (PST), 9am (Mexico City) 10am (EST, Lima, Panama), 12m (Buenos Aires), 1pm (Brasilia, Rio), 3pm (London), 4pm (CST), 5pm (Johannesburg), 10pm (Bangkok), 2am+1 (Sydney). For other locations, please check:

     

    http://www.worldtimeserver.com/meeting-planner.aspx

     

    PrEP and Adolescents at Risk: Existing Evidence and Plans for a Demonstration Study
    (22 November)

    sibil hosek

    Sybil Hosek is a Clinical Psychologist/HIV Researcher at Stroger Hospital of Cook County with over 15 years experience in the development and implementation of HIV-related research studies and behavioral interventions. Her current research focuses on biomedical primary prevention interventions, for adolescents and young adults, including PrEP and microbicides, and the development of behavioral interventions to improve uptake and adherence to these new biomedical strategies. Dr. Hosek is currently vice-chair of the IMPAACT Prevention Scientific Committee, a member of the HPTN Adolescents At Risk Scientific Committee, and co-chair of the HANC Youth Prevention Research Working Group.

     

    Alejandra Trossero

    Alejandra Trossero recently joined UNICEF Latin American and the Caribbean Regional office as the Regional Adolescent and HIV/AIDS Specialist. Alejandra has over 18 years of experience working on HIV and sexual and reproductive health (SRH). Prior to joining UNICEF, she hold positions at UNDP and the International Planned Parenthood Federation (IPPF), focusing on HIV and SRH integration, establishing a 5-year research program in three Sub-Saharan Africa countries to assess the efficacy and cost-benefit of integrating HIV and SRH services – with Population Council and London School of Hygiene and Tropical Medicine. She is currently serving as the Chair of the Program Advisory Panel at the Robert Carr Civil Society Network Fund. Alejandra, who hails from Argentina, has a degree in Psychology and a Masters in Science in Reproductive and Sexual Health Research from the London School of Hygiene and Tropical Medicine.

    To register for the webinar please click on the following link:

     

    https://goo.gl/forms/gHS3HsaflKdvBpU02

     

    ARV-based prevention and PrEP research - News from the 2016 Research for Prevention Conference
    (28 November)

    Rafael Landovitz

    Raphael J Landovitz´s clinical research career focuses on optimizing the use of HIV antiretroviral therapy for both HIV treatment and HIV prevention.
    Dr. Landovitz was trained at Princeton University and Harvard Medical School. He completed post-graduate training in internal medicine at Brigham and Women’s Hospital (1996-1999) and Infectious Diseases and HIV Medicine at Brigham and Women’s Hospital and Massachusetts General Hospital (1999-2001). The served as Chief Medical Resident at the Brigham and Women’s Hospital from 2001-2002. He served on the faculty of the Division of Infectious Diseases at the Brigham and Women’s Hospital from 2001-2005, and then as Medical Co-Director of the Vietnam CDC-Harvard Medical School AIDS Partnership. He is Currently Associate Professor of Medicine in the Division of Infectious Diseases at UCLA, Associate Director of the UCLA Center for Clinical AIDS Research & Education, and Co-Director of the UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS). He is leading the NIH/DAIDS funded Phase 2a and Phase 3 studies of long-acting injectable PrEP using cabotegravir (GSK 1265744). He was awarded the John Carey Young Investigator Award by the AIDS Clinical Trials Group in 2010..

    To register for the webinar please click on the following link:

     

    https://goo.gl/forms/2BxXvMKKGb0AYsKI2

     

    PrEP in the Wild - An interim Analysis
    (05 December)

    Jerome Galea

    Jerome Galea is the Deputy Director of Partners in Health and the co-founder of the LGTB Epicenter community center, both organizations in Lima, Peru, and a postdoctoral Fellow at the Harvard Medical School. He has studied and published on the acceptability of PrEP in Peru and is currently investigating the informal use of PrEP in the Wild PrEP study.

    To register for the webinar please click on the following link:

     

    https://goo.gl/forms/0xsEvSQuFL8BHflE2

     

    After you register you will receive a confirmation e-mail with instructions to access the webinar and background readings.Looking forward to your participation. 

     

    Read more

  • NEMUS Webinar Latina# 7: "Implementación de PrEP en América Latina:…

    Estimadas y estimados colegas:

     

    En una etapa en la cual la región comienza a considerar cada vez más claramente la posibilidad de incluir PrEP en el marco de los esfuerzos de prevención combinada del VIH, resulta de interés conocer las lecciones del Estudio iPrEx OLE que pueden ser de utilidad en dichos esfuerzos. El Estuido iPrEx OLE fue la extensión de etiqueta abierta del estudio iPrEx, realizado en Brasil, Ecuador, Estados Unidos, Perú, Sudáfrica y Tailandia; si bien no fue un estudio demostrativo en servicios públicos de salud, nos puede ofrecer aportes valiosos en una etapa en que otros estudios demostrativos recién están siendo implementados o, incluso, planeados. Por ello, el proximo jueves 3 de Noviembre el Dr. Juan Vicente Guanira nos presentará:

     

    "Implementación de PrEP en América Latina: Aportes del Estudio iPrEx OLE"

     

    guanira 200

    El Dr Juan Guanira es medico graduado en la Universidad Peruana Cayetano Heredia y obtuvo una Maestría en Salud Publica con mención en Epidemiologia en la Universidad de Washington, en Seattle EEUU. Tiene mas de 15 años de experiencia en el campo de la investigación en prevención del VIH. Ha sido investigador de una de las sedes del estudio iPrEx que demostró la eficacia de PrEP en Hombres y sirvió para la aprobación de la indicación de PrEP para Truvada. Actualmente es investigador asociado del Secretariado de NEMUS (Network for Multidisciplinary Studies on ARV-Based Prevetion for HIV). Es también Director Ejecutivo de Investigaciones Médicas en Salud (INMENSA), una ONG dedicada a la investigación, prevención y atención del VIH en Lima, Peru.

     

     

    El webinar se desarrollará el Miercoles 03 de Noviembre de 2016 a las 8:00 am en Los Angeles, 9:00am en C. de Guatemala, y San José; 10.00am en Ciudad de México, Bogotá, Lima, Quito y Ciudad de Panamá; 11:00am en Santo Domingo, Washington, La Paz, La Habana y Santiago; 12:00m en Brasilia y Buenos Aires; 4:00pm en Lisboa y Londres; y 5pm en Madrid y París. Para otros países/ciudades, por favor visite:

     

    http://www.worldtimeserver.com/meeting-planner.aspx

     

    Para registrarse para el webinar, por favor ingrese en:

     

    https://goo.gl/forms/3EMbRZLBfQKXf4Cj1

     

    Luego de registrarse recibirá un mensaje confirmatorio con instrucciones para ingresar al webinar vía gotomeeting, y lecturas de apoyo. Esperamos contar con su participación.

     

     

     

     

    Read more

    close
    wxxxxxxxxxx
    NEMUS Webinar Latina# 7: "Implementación de PrEP en América Latina: Aportes del Estudio iPrEx OLE"

    Estimadas y estimados colegas:

     

    En una etapa en la cual la región comienza a considerar cada vez más claramente la posibilidad de incluir PrEP en el marco de los esfuerzos de prevención combinada del VIH, resulta de interés conocer las lecciones del Estudio iPrEx OLE que pueden ser de utilidad en dichos esfuerzos. El Estuido iPrEx OLE fue la extensión de etiqueta abierta del estudio iPrEx, realizado en Brasil, Ecuador, Estados Unidos, Perú, Sudáfrica y Tailandia; si bien no fue un estudio demostrativo en servicios públicos de salud, nos puede ofrecer aportes valiosos en una etapa en que otros estudios demostrativos recién están siendo implementados o, incluso, planeados. Por ello, el proximo jueves 3 de Noviembre el Dr. Juan Vicente Guanira nos presentará:

     

    "Implementación de PrEP en América Latina: Aportes del Estudio iPrEx OLE"

     

    guanira 200

    El Dr Juan Guanira es medico graduado en la Universidad Peruana Cayetano Heredia y obtuvo una Maestría en Salud Publica con mención en Epidemiologia en la Universidad de Washington, en Seattle EEUU. Tiene mas de 15 años de experiencia en el campo de la investigación en prevención del VIH. Ha sido investigador de una de las sedes del estudio iPrEx que demostró la eficacia de PrEP en Hombres y sirvió para la aprobación de la indicación de PrEP para Truvada. Actualmente es investigador asociado del Secretariado de NEMUS (Network for Multidisciplinary Studies on ARV-Based Prevetion for HIV). Es también Director Ejecutivo de Investigaciones Médicas en Salud (INMENSA), una ONG dedicada a la investigación, prevención y atención del VIH en Lima, Peru.

     

     

    El webinar se desarrollará el Miercoles 03 de Noviembre de 2016 a las 8:00 am en Los Angeles, 9:00am en C. de Guatemala, y San José; 10.00am en Ciudad de México, Bogotá, Lima, Quito y Ciudad de Panamá; 11:00am en Santo Domingo, Washington, La Paz, La Habana y Santiago; 12:00m en Brasilia y Buenos Aires; 4:00pm en Lisboa y Londres; y 5pm en Madrid y París. Para otros países/ciudades, por favor visite:

     

    http://www.worldtimeserver.com/meeting-planner.aspx

     

    Para registrarse para el webinar, por favor ingrese en:

     

    https://goo.gl/forms/3EMbRZLBfQKXf4Cj1

     

    Luego de registrarse recibirá un mensaje confirmatorio con instrucciones para ingresar al webinar vía gotomeeting, y lecturas de apoyo. Esperamos contar con su participación.

     

     

     

    Read more

  • NEMUS Webinar Latina# 6: O Estudio Demonstrativo PrEP-Brasil: Dados do…

    Estimadas y estimados colegas:

     

    América Latina ha sido escenario parcial del más importante ensayo clínico sobre profilaxis pre-exposición en HSH: el estudio iPrEx. Y, aunque pronto habrán otros, en la actualidad solo hay un estudio demostrativo de PrEP en HSH y mujeres trans: El estudio PrEP-Brasil. Involucrada en ambos estudios, la Dra. Beatriz Grinstejn es una de las investigadoras con mayor experiencia en el tema. Este miercoles 28 de septiembre, en nuestro próximo webinar de NEMUS Latina, ella presentará sobre:

     

    "El Estudio Demostrativo PrEP-Brasil: Datos de Reclutamiento e Inicio del Seguimiento"

     

    Beatriz Grinsztejn

    Beatriz Grinsztejn es directora del Laboratorio de Investigación Clínica de ITS / SIDA en el Instituto de Investigación Clínica Evandro Chagas (IPEC / Fiocruz) e investigadora principal de la Unidad de Prevención del VIH y ensayos clínicos terapéuticos, que se enfoca en prevención del VIH de base comunitaria, y en ensayos clínicos terapéuticos y estudios de cohorte en Río de Janeiro, Brasil. La Dra. Grinsztejn es también Médica Infectóloga e Investigadora de la Fundación Oswaldo Cruz; así como asesora técnica del Comité Consultivo de Brasil para la terapia antirretroviral en adultos; y miembro del Panel Científico de ONUSIDA. Actualmente lidera varios proyectos en Brasil para expandir y mejorar la investigación biomédica en la prevención para HSH y mujeres trans, incluyendo la prevención basada en antiretrovirales, y el diagnóstico y tratamiento de la infección aguda por VIH.

     

     

    El webinar se desarrollará el Miercoles 28 de Setiembre de 2016 a las 8:00 am en Los Angeles, 9:00am en C. de Guatemala, y San José; 10.00am en Ciudad de México, Bogotá, Lima, Quito y Ciudad de Panamá; 11:00am en Santo Domingo, Washington, La Paz, La Habana y Santiago; 12:00m en Brasilia y Buenos Aires; 4:00pm en Lisboa y Londres; y 5pm en Madrid y París. Para otros países/ciudades, por favor visite:

     

    http://www.worldtimeserver.com/meeting-planner.aspx

     

    Para registrarse para el webinar, por favor ingrese en:

     

    https://goo.gl/forms/j7rpk4tC5SmEkOL93

     

    Luego de registrarse recibirá un mensaje confirmatorio con instrucciones para ingresar al webinar vía gotomeeting, y lecturas de apoyo. Esperamos contar con su participación.

     

     

     

     

    Read more

    close
    wxxxxxxxxxx
    NEMUS Webinar Latina# 6: O Estudio Demonstrativo PrEP-Brasil: Dados do recrutamento e início do seguimento

    Estimadas y estimados colegas:

     

    América Latina ha sido escenario parcial del más importante ensayo clínico sobre profilaxis pre-exposición en HSH: el estudio iPrEx. Y, aunque pronto habrán otros, en la actualidad solo hay un estudio demostrativo de PrEP en HSH y mujeres trans: El estudio PrEP-Brasil. Involucrada en ambos estudios, la Dra. Beatriz Grinstejn es una de las investigadoras con mayor experiencia en el tema. Este miercoles 28 de septiembre, en nuestro próximo webinar de NEMUS Latina, ella presentará sobre:

     

    "El Estudio Demostrativo PrEP-Brasil: Datos de Reclutamiento e Inicio del Seguimiento"

     

    Beatriz Grinsztejn

    Beatriz Grinsztejn es directora del Laboratorio de Investigación Clínica de ITS / SIDA en el Instituto de Investigación Clínica Evandro Chagas (IPEC / Fiocruz) e investigadora principal de la Unidad de Prevención del VIH y ensayos clínicos terapéuticos, que se enfoca en prevención del VIH de base comunitaria, y en ensayos clínicos terapéuticos y estudios de cohorte en Río de Janeiro, Brasil. La Dra. Grinsztejn es también Médica Infectóloga e Investigadora de la Fundación Oswaldo Cruz; así como asesora técnica del Comité Consultivo de Brasil para la terapia antirretroviral en adultos; y miembro del Panel Científico de ONUSIDA. Actualmente lidera varios proyectos en Brasil para expandir y mejorar la investigación biomédica en la prevención para HSH y mujeres trans, incluyendo la prevención basada en antiretrovirales, y el diagnóstico y tratamiento de la infección aguda por VIH.

     

     

    El webinar se desarrollará el Miercoles 28 de Setiembre de 2016 a las 8:00 am en Los Angeles, 9:00am en C. de Guatemala, y San José; 10.00am en Ciudad de México, Bogotá, Lima, Quito y Ciudad de Panamá; 11:00am en Santo Domingo, Washington, La Paz, La Habana y Santiago; 12:00m en Brasilia y Buenos Aires; 4:00pm en Lisboa y Londres; y 5pm en Madrid y París. Para otros países/ciudades, por favor visite:

     

    http://www.worldtimeserver.com/meeting-planner.aspx

     

    Para registrarse para el webinar, por favor ingrese en:

     

    https://goo.gl/forms/j7rpk4tC5SmEkOL93

     

    Luego de registrarse recibirá un mensaje confirmatorio con instrucciones para ingresar al webinar vía gotomeeting, y lecturas de apoyo. Esperamos contar con su participación.

     

     

     

    Read more

  • NEMUS Webinar # 24: PrEP: From clinical trials to prevention…

    Dear colleague:

     

    The XXI AIDS International Conference returned this year to Durban, South Africa, from 17 to 22 July 2016. As expected, PrEP was an important topic this year, as we start to move to implementation. Next Tuesday, 13 September, we will be honored to have Dr. Patrick Sullivan, who served as Rapporteur for Track C, presenting a summary of PrEP-related news from Durban in our next NEMUS webinar, entitled:

     

    PrEP: From clinical trials to prevention reality - Perspectives from Durban

     

    Patrick Sullivan

    Dr. Patrick Sullivan. is a Professor of Epidemiology at Emory University’s Rollins School of Public Health, the Co-Director of the Prevention Sciences Core at Emory’s Center for AIDS Research (CFAR), and a member of the US Presidential Advisory Council on HIV/AIDS. Dr. Sullivan’s career has included work on HIV surveillance at the US Centers for Disease Control and Prevention, HIV Vaccine Research at NIH-supported HIV Vaccine Trials Network, and research on HIV prevention for MSM supported by the US NIH. He currently leads studies of PrEP for MSM in the United States and South Africa, and has developed a _home care” system for MSM on PrEP to reduce the need for clinic visits for interval monitoring of PrEP.

    The webinar is scheduled to take place on Tuesday 13 September, 2016 at 7:00 am Los Angeles; 9:00 am Mexico, Lima, Panama City; 10:00 New York; 11:00 am Brasilia; 3:00 pm London; 4:00 pm Geneva/Johannesburg, 7.30 pm India, 9pm Bangkok. To check the time in your specific time zone, please visit:

     

    http://www.worldtimeserver.com/meeting-planner.aspx

     

    To register for the webinar please click on the following link:

     

    https://goo.gl/forms/hKYgZxs8Cgq91Y353

     

    After you register you will receive a confirmation e-mail with instructions to access the webinar and background readings.Looking forward to your participation.

     

     

     

     

    Read more

    close
    wxxxxxxxxxx
    NEMUS Webinar # 24: PrEP: From clinical trials to prevention reality - Perspectives from Durban

    Dear colleague:

     

    The XXI AIDS International Conference returned this year to Durban, South Africa, from 17 to 22 July 2016. As expected, PrEP was an important topic this year, as we start to move to implementation. Next Tuesday, 13 September, we will be honored to have Dr. Patrick Sullivan, who served as Rapporteur for Track C, presenting a summary of PrEP-related news from Durban in our next NEMUS webinar, entitled:

     

    PrEP: From clinical trials to prevention reality - Perspectives from Durban

     

    Patrick Sullivan

    Dr. Patrick Sullivan. is a Professor of Epidemiology at Emory University’s Rollins School of Public Health, the Co-Director of the Prevention Sciences Core at Emory’s Center for AIDS Research (CFAR), and a member of the US Presidential Advisory Council on HIV/AIDS. Dr. Sullivan’s career has included work on HIV surveillance at the US Centers for Disease Control and Prevention, HIV Vaccine Research at NIH-supported HIV Vaccine Trials Network, and research on HIV prevention for MSM supported by the US NIH. He currently leads studies of PrEP for MSM in the United States and South Africa, and has developed a _home care” system for MSM on PrEP to reduce the need for clinic visits for interval monitoring of PrEP.

    The webinar is scheduled to take place on Tuesday 13 September, 2016 at 7:00 am Los Angeles; 9:00 am Mexico, Lima, Panama City; 10:00 New York; 11:00 am Brasilia; 3:00 pm London; 4:00 pm Geneva/Johannesburg, 7.30 pm India, 9pm Bangkok. To check the time in your specific time zone, please visit:

     

    http://www.worldtimeserver.com/meeting-planner.aspx

     

    To register for the webinar please click on the following link:

     

    https://goo.gl/forms/hKYgZxs8Cgq91Y353

     

    After you register you will receive a confirmation e-mail with instructions to access the webinar and background readings.Looking forward to your participation.

     

     

     

    Read more

Nemus TV

We plan to broadcast presentations and events relevant to NEMUS

Why register?

 

We hope to reach two kinds of users of this website:

a) General users (unregistered), with non-specific or temporary interest on this topic. They will access the general content and most of the resources.

b) Registered Members, who will have to register initially, and then to log-in for access. They will be identified by name and contact information (although this list will be internal), and will provide details of their background connection with the topic. It is assumed that they have closer links with the issue of ARV-based prevention (through their work as prevention programme managers, health care providers, advocates, and researchers). They will have access to discussions 'by invitation only' and draft documents of restricted circulation. They will become members of NEMUS.

If you wish to become a member, please

 

Register now

Contact Us

We will reply to each and every submission. If there are any new projects or publications we should know about please feel free to drop us a line with the details

Name must not be empty
Please provide a valid email
Message should not be empty
Captcha should not be empty

NEMUS Secretariat

 

Unit of Health, Sexuality and Human Development
Cayetano Heredia University
Av. Armendariz 445, Miraflores
Lima 18, Peru

511.203.3300

nemus.secretariat[at]nemus-hiv.net

Newsletter

 

We will publish a bimonthly bulletin with original notes or links to notes that are relevant to NEMUS' activities, including research initiatives and findings, policy debates, dissemination efforts, among others.